Mabpharm-B (02335.HK) proposes to adopt an H share incentive scheme and seeks shareholder authorization for an H share repurchase mandate

Zhitong Finance APP news, Maike Medicine-B (02335.HK) announced that on October 15, 2026 (after trading hours), the Board resolved to propose the adoption of the H Share Incentive Scheme for shareholder approval, and will seek shareholder authorization for the H Share Buyback Mandate at an extraordinary general meeting convened by the Company.